Back to Search
Start Over
21MO Primary results of a China bridging, phase II randomized study of initial endocrine therapy (ET) ± ribociclib (RIB) in pre- & postmenopausal Chinese women with HR+/HER2– ABC.
- Source :
-
Annals of Oncology . Nov2022 Suppl 9, Vol. 33, pS1438-S1438. 1p. - Publication Year :
- 2022
- Subjects :
- *CHINESE people
*HORMONE therapy
*POSTMENOPAUSE
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 160397944
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.10.030